The store will not work correctly when cookies are disabled.
N-cyclopropyl-4-methyl-2-oxo-1-oxaspiro[4.5]dec-3-ene-3-carboxamide
ID: ALA4755999
PubChem CID: 155394896
Max Phase: Preclinical
Molecular Formula: C14H19NO3
Molecular Weight: 249.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC1=C(C(=O)NC2CC2)C(=O)OC12CCCCC2
Standard InChI: InChI=1S/C14H19NO3/c1-9-11(12(16)15-10-5-6-10)13(17)18-14(9)7-3-2-4-8-14/h10H,2-8H2,1H3,(H,15,16)
Standard InChI Key: NIMPVTMUGZONIB-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
2.6290 -5.7534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8119 -5.7492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4020 -6.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8047 -7.1613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6219 -7.1655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0363 -6.4592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1144 -5.9061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1144 -4.2717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1144 -3.4545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4091 -5.5016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4091 -4.6844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6320 -4.4319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1516 -5.0930 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3795 -3.6546 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8227 -4.6827 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5316 -4.2762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3476 -4.2827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9410 -3.5738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
11 8 1 0
10 7 1 0
15 8 1 0
8 9 2 0
10 11 2 0
11 12 1 0
12 13 1 0
13 1 1 0
1 10 1 0
12 14 2 0
15 16 1 0
17 16 1 0
18 17 1 0
16 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 249.31 | Molecular Weight (Monoisotopic): 249.1365 | AlogP: 1.84 | #Rotatable Bonds: 2 |
Polar Surface Area: 55.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 1.97 | CX LogD: 1.97 |
Aromatic Rings: ┄ | Heavy Atoms: 18 | QED Weighted: 0.60 | Np Likeness Score: 0.05 |
References
1. Hayek S,Pietrancosta N,Hovhannisyan AA,Alves de Sousa R,Bekaddour N,Ermellino L,Tramontano E,Arnould S,Sardet C,Dairou J,Diaz O,Lotteau V,Nisole S,Melikyan G,Herbeuval JP,Vidalain PO. (2020) Cerpegin-derived furo[3,4-c]pyridine-3,4(1H,5H)-diones enhance cellular response to interferons by de novo pyrimidine biosynthesis inhibition., 186 [PMID:31740051] [10.1016/j.ejmech.2019.111855] |